Cargando…
Disregulations of PURPL and MiR-338-3p Could Serve As Prognosis Biomarkers for Epithelial Ovarian Cancer
Objective: The present study aimed to explore the expressions of long noncoding RNA (lncRNA) p53 upregulated regulator of p53 levels (PURPL) in different ovarian tissues, and to evaluate the significance of disregulations of PURPL and microRNA-338-3p (miR-338-3p) in epithelial ovarian cancer (EOC)....
Autores principales: | Zhang, Ruitao, He, Tingting, Shi, Huirong, Yuan, Cao, Wei, Feng, Liu, Zheying, Wang, Wenwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364645/ https://www.ncbi.nlm.nih.gov/pubmed/34405027 http://dx.doi.org/10.7150/jca.61327 |
Ejemplares similares
-
Down-regulation of miR-338-3p and Up-regulation of MACC1 Indicated Poor Prognosis of Epithelial Ovarian Cancer Patients
por: Zhang, Ruitao, et al.
Publicado: (2019) -
Abnormal expressions of PURPL, miR-363-3p and ADAM10 predicted poor prognosis for patients with ovarian serous cystadenocarcinoma
por: Zhang, Ruitao, et al.
Publicado: (2023) -
MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways
por: Zhang, Ruitao, et al.
Publicado: (2019) -
Epigenetic Disregulation in Oral Cancer
por: Mascolo, Massimo, et al.
Publicado: (2012) -
Biofeedback and the behavioral treatment of disorders of disregulation.
por: Schwartz, G. E.
Publicado: (1979)